APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors
暂无分享,去创建一个
Nicholette D. Palmer | Amudha | A. Israni | C. Langefeld | A. Kirk | J. Divers | N. Palmer | D. Bowden | B. Freedman | B. Julian | R. Stratta | J. Rogers | D. Schladt | P. Hicks | R. Gaston | G. Orlando | A. Farney | Lijun Ma | W. M. Brown | R. Bray | H. Gebel | S. Mohan | S. Pastan | M. Gautreaux | V. Hauptfeld | A. Palanisamy | A. Reeves-Daniel | Palanisamy | David | Schladt | Jeffrey Rogers | J. Robert | Stratta
[1] K. Skorecki,et al. APOL1 nephropathy: from gene to mechanisms of kidney injury. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] A. Dreher. Modeling Survival Data Extending The Cox Model , 2016 .
[3] Nicholette D. Palmer,et al. Apolipoprotein L1 Gene Variants in Deceased Organ Donors Are Associated With Renal Allograft Failure , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] G. Knoll,et al. APOL1 Genotyping of African American Deceased Organ Donors: Not Just Yet , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[5] B. Freedman,et al. Should kidney donors be genotyped for APOL1 risk alleles? , 2015, Kidney international.
[6] K. Skorecki,et al. Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy. , 2014, Clinical journal of the American Society of Nephrology : CJASN.
[7] Bertram L Kasiske,et al. New national allocation policy for deceased donor kidneys in the United States and possible effect on patient outcomes. , 2014, Journal of the American Society of Nephrology : JASN.
[8] O. Gribouval,et al. APOL1 polymorphisms and development of CKD in an identical twin donor and recipient pair. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[9] Nicholette D. Palmer,et al. Gene-gene interactions in APOL1-associated nephropathy. , 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[10] Nicholette D. Palmer,et al. APOL1 and progression of nondiabetic nephropathy. , 2013, Journal of the American Society of Nephrology : JASN.
[11] M. Rocco,et al. JC polyoma virus interacts with APOL1 in African Americans with non-diabetic nephropathy , 2013, Kidney international.
[12] A. Israni,et al. Scientific Registry of Transplant Recipients: collecting, analyzing, and reporting data on transplantation in the United States. , 2013, Transplantation reviews.
[13] D. Slakey,et al. The Contribution of Donor Quality to Differential Graft Survival in African American and Caucasian Renal Transplant Recipients , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[14] G. Genovese,et al. The APOL1 Genotype of African American Kidney Transplant Recipients Does Not Impact 5‐Year Allograft Survival , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] M. Rocco,et al. Association of APOL1 variants with mild kidney disease in first-degree relatives of African American patients with non-diabetic end stage renal disease , 2012, Kidney international.
[16] M. Rocco,et al. The APOL1 Gene and Allograft Survival after Kidney Transplantation , 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[17] C. Winkler,et al. Association of Trypanolytic ApoL1 Variants with Kidney Disease in African Americans , 2010, Science.
[18] S. Rosset,et al. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene , 2010, Human Genetics.
[19] R. Steiner. ‘Normal for Now’ or ‘At Future Risk’: A Double Standard for Selecting Young and Older Living Kidney Donors , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[20] R. Wolfe,et al. Effect of changing the priority for HLA matching on the rates and outcomes of kidney transplantation in minority groups. , 2004, The New England journal of medicine.
[21] J. Curtis,et al. Kidney transplantation: racial or socioeconomic disparities? , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[22] Robert Gray,et al. A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .
[23] John O'Quigley,et al. An application of changepoint methods in studying the effect of age on survival in breast cancer , 1999 .
[24] E. Meydrech,et al. Racial differences in the survival of cadaveric renal allografts. Overriding effects of HLA matching and socioeconomic factors. , 1992, The New England journal of medicine.
[25] L. J. Wei,et al. The Robust Inference for the Cox Proportional Hazards Model , 1989 .
[26] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[27] D.,et al. Regression Models and Life-Tables , 2022 .